Atrium Therapeutics Inc (RNA)

Currency in USD
7.130
-0.380(-5.06%)
Real-time Data·
Trading near 52-week Low
RNA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.1307.690
52 wk Range
7.13016.770
Key Statistics
Prev. Close
7.51
Open
7.54
Day's Range
7.13-7.69
52 wk Range
7.13-16.77
Volume
67.08K
Average Volume (3m)
289.67K
1-Year Change
-
Book Value / Share
11.99
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RNA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
22.000
Upside
+208.56%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Atrium Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 22.000
(+208.56% Upside)

Earnings

Latest Release
12-11-2026
EPS / Forecast
-0.25 / --
Revenue / Forecast
15.32M / --
EPS Revisions
Last 90 days

RNA Income Statement

Compare RNA to Peers and Sector

Metrics to compare
RNA
Peers
Sector
Relationship
P/E Ratio
−2.3x−14.2x−0.2x
PEG Ratio
0.02−0.090.00
Price/Book
0.8x3.4x2.6x
Price / LTM Sales
4.2x3.6x2.8x
Upside (Analyst Target)
203.4%162.8%65.0%
Fair Value Upside
Unlock13.1%9.5%Unlock

Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company’s development stage product candidates include ATR 1072, a siRNA-based therapy targeting PRKAG2 for the treatment of PRKAG2 syndrome; and ATR 1086, a siRNA-based therapy targeting PLN for the treatment of PLN cardiomyopathy. It also focuses on pipeline to treat a range of genetic and cardiac diseases. It has a research collaboration and license agreement with Bristol-Myers Squibb Company and Eli Lilly and Company. The company was incorporated in 2025 and is headquartered in San Diego, California. Atrium Therapeutics, Inc. was formerly a subsidiary of Avidity Biosciences, Inc.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
3.65M21.32%27.39M
Other Institutional Investors
10.37M60.65%77.92M
Public Companies & Retail Investors
3.08M18.03%23.16M
Total
17.11M100.00%128.46M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Sessa Capital IM, L.P.8.77%15,00,00011,265
T. Rowe Price Group, Inc.8.61%14,72,98411,062

FAQ

What Is the Atrium Therapeutics (RNA) Share Price Today?

The Atrium Therapeutics share price today is 7.130.

What is the current Atrium Therapeutics (RNA) share price and day range?

As of 16-11-2026, the Atrium Therapeutics share price is 7.130, with a previous close of 7.510. The share price has ranged from 7.130 to 7.690 today, while the 52-week range spans from 7.130 to 16.770.

What Is the Atrium Therapeutics Market Cap?

As of today, Atrium Therapeutics market cap is 162.000M.

What Is the Atrium Therapeutics (RNA) Share Price Target?

The average 12-month share price target for Atrium Therapeutics is 22.000, with a high estimate of 25 and a low estimate of 15. 5 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +208.56% Upside potential.

What Is Atrium Therapeutics's Earnings Per Share (TTM)?

The Atrium Therapeutics EPS (TTM) is -4.28.

From a Technical Analysis Perspective, Is RNA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does Atrium Therapeutics Trade On?

Atrium Therapeutics is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Atrium Therapeutics?

The stock symbol for Atrium Therapeutics is "RNA."

How Many Times Has Atrium Therapeutics Stock Split?

Atrium Therapeutics has split 0 times.

What Is the RNA After Hours Price?

RNA's last after hours stock price is 7.500, the stock has changed by -0.010, or -0.130%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.